Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07637630 · ClinicalTrials.gov registry record · NA
Trial in HPV Prevention for the U.S. Vietnamese Community
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT07637630: Recruiting NA study, sponsored by Northwestern University.
NCT07637630 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07637630, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietnamese. PRIMARY AIM To assess the feasibility and acceptability of each of the four digital HERO intervention components in a pilot optimization trial using the MOST framework. Using a highly efficient design, the study team will randomize 96 Vietnamese parents of unvaccinated adolescents to receive 0 to 4 HERO components. The study team will establish the feasibility (reach, retention, adherence) and acceptability (usability, satisfaction, usefulness, cultural relevance) of each component (expert video, self-persuasion, narrative storytelling, and motivational interviewing). SECONDARY AIM To investigate effects of each component on HPV vaccination outcomes and psychosocial mediators. The study team will examine the effects on HPV vaccination (initiation and intention) and psychosocial mediators.
Primary Outcome
Number of enrolled participants divided by number of eligible individuals
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Expert Video
- BEHAVIORAL Self-persuasion
- BEHAVIORAL Narrative Storytelling
- BEHAVIORAL Constant Component
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT07637630 shows while recruiting
NCT07637630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Motivational Interviewing is the first listed.
NCT07637630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07637630 about?
NCT07637630 is a clinical study titled "Trial in HPV Prevention for the U.S. Vietnamese Community". The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietn...
What is the current status of trial NCT07637630?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2026-05-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07637630?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Expert Video (BEHAVIORAL), Self-persuasion (BEHAVIORAL), Narrative Storytelling (BEHAVIORAL), Constant Component (BEHAVIORAL).
Who is sponsoring clinical trial NCT07637630?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07637630's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI